Q9NZ08 (ERAP1_HUMAN) Homo sapiens (Human)
Endoplasmic reticulum aminopeptidase 1 UniProtKBInterProSTRINGInteractive Modelling
941 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
14 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| High-resolution crystal structure of ERAP1 in complex with 15mer phosphinic peptide |
Heteromer P04578; | 100.0 | 2×NAG; 1×ZN; 1×B3P; 21×EDO; 4×NA; 1×PPI; 2×NAG; | |||
| ERAP1 binds peptide C-terminus of a LPF sequence (AAAAFKARKF) | homo-2-mer | 100.0 | ||||
| ERAP1 binds peptide C-terminus of a SPF sequence (FKARKF) | homo-2-mer | 100.0 | ||||
| Crystal structure of the soluble domain of human endoplasmic reticulum aminopeptidase 1 ERAP1 | monomer | 100.0 | 2×NAG; 1×NAG; 1×ZN; 2×K; 1×EDO; 1×BES; | |||
| Human ERAP1 bound to phosphinic pseudotripeptide inhibitor DG013 | monomer | 100.0 | 2×NAG; 1×ZN; 1×P52; 13×SO4; 1×NAG; | |||
| ERAP1 in the open conformation bound to 10mer phosphinic inhibitor DG014 | monomer | 99.53 | 1×NAG; 1×NAG; 1×ZN; 1×UNX; | |||
| High-resolution crystal structure of ERAP1 with bound phosphinic transition-state analogue inhibitor | monomer | 100.0 | 1×NAG; 1×NAG; 2×NAG; 1×ZN; 1×HJ5; 1×B3P; 30×EDO; 1×MLT; 1×P6G; 1×PG4; 3×NA; | |||
| High-resolution crystal structure of ERAP1 in complex with 10mer phosphinic peptide | monomer | 100.0 | 1×NAG; 1×NAG; 1×NAG; 1×NAG; 1×ZN; 11×SCN; 22×EDO; 4×NA; 3×PGE; | |||
| High-resolution crystal structure of ERAP1 with bound bestatin analogue inhibitor | monomer | 100 | 1×NAG; 1×NAG; 1×ZN; 1×I88; 18×EDO; 1×MLT; 1×PGE; | |||
| Human endoplasmic reticulum aminopeptidase 1 (ERAP1) in complex with (4aR,5S,6R,8S,8aR)-5-(2-(Furan… | monomer | 99.32 | 1×ZN; 2×MLT; 18×EDO; 1×MNZ; | |||
| Crystal structure of the open state of human endoplasmic reticulum aminopeptidase 1 ERAP1 | monomer | 100.0 | 1×NAG; 1×ZN; | |||
| ER Aminopeptidase, ERAP1, Bound to the Zinc Aminopeptidase Inhibitor, Bestatin | monomer | 99.63 | 1×NAG; 1×ZN; 1×BES; 2×NAG; | |||
| Crystal Structure of ERAP1 Peptide Binding Domain | monomer | 100.0 | 2×EDO; | |||
| crystal structure of antigen-ERAP1 domain complex | monomer | 100.0 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6q4r.1.A | monomer | 0.88 | 1×ZN; 1×HJ5; 1×B3P; 1×MLT; | 99.67 | ||
| 7p7p.1.A | monomer | 0.80 | 1×ZN; | 52.63 | ||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 6rqx.1.A | monomer | 0.87 | 1×KF2; 1×ZN; | 100.00 | ||
| Isoform 2 | 7p7p.1.A | monomer | 0.80 | 1×ZN; | 52.63 | ||